Citterio, Franco
 Distribuzione geografica
Continente #
EU - Europa 12.261
NA - Nord America 4.625
AS - Asia 1.410
AF - Africa 79
SA - Sud America 48
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 18.438
Nazione #
IT - Italia 8.534
US - Stati Uniti d'America 4.571
DE - Germania 1.005
SE - Svezia 638
CN - Cina 569
UA - Ucraina 515
SG - Singapore 423
NL - Olanda 326
IE - Irlanda 259
FR - Francia 248
ID - Indonesia 155
PL - Polonia 141
FI - Finlandia 134
GB - Regno Unito 128
RU - Federazione Russa 101
IN - India 88
CH - Svizzera 56
CI - Costa d'Avorio 49
BE - Belgio 44
TR - Turchia 39
CA - Canada 38
ES - Italia 31
JP - Giappone 30
BR - Brasile 28
IR - Iran 26
CZ - Repubblica Ceca 15
VN - Vietnam 13
AT - Austria 12
HK - Hong Kong 12
MX - Messico 12
CO - Colombia 10
MA - Marocco 10
RO - Romania 10
PK - Pakistan 9
GR - Grecia 8
TW - Taiwan 8
BD - Bangladesh 7
BG - Bulgaria 7
CL - Cile 7
TH - Thailandia 7
AU - Australia 5
EG - Egitto 5
HU - Ungheria 5
LT - Lituania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
KR - Corea 4
NO - Norvegia 4
PH - Filippine 4
PT - Portogallo 4
SA - Arabia Saudita 4
SI - Slovenia 4
SM - San Marino 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
DZ - Algeria 3
MD - Moldavia 3
MY - Malesia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
A1 - Anonimo 2
AL - Albania 2
CV - Capo Verde 2
EU - Europa 2
IL - Israele 2
IS - Islanda 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
UG - Uganda 2
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
GT - Guatemala 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
PE - Perù 1
PY - Paraguay 1
SD - Sudan 1
Totale 18.438
Città #
Chandler 1.028
Milan 911
Rome 609
Ashburn 370
Singapore 303
Naples 255
Jacksonville 247
San Mateo 246
Dublin 245
Turin 175
Wilmington 162
New York 154
Jakarta 151
Nanjing 129
Ann Arbor 127
Florence 122
Bologna 120
Palermo 113
Fairfield 111
Boston 109
Lawrence 94
Cattolica 93
Bari 85
Catania 83
Genoa 82
Dearborn 79
Beijing 77
Warsaw 72
Redwood City 67
Moscow 64
Houston 59
Verona 55
Princeton 54
Seattle 51
Kraków 50
Abidjan 49
Nürnberg 49
Woodbridge 48
Brescia 46
Padova 40
Nanchang 39
Venice 39
Guangzhou 36
Parma 35
Redmond 35
Brussels 34
Mountain View 34
Chicago 32
Perugia 31
Los Angeles 30
Boardman 29
Hangzhou 29
Lancaster 29
Bergamo 28
Messina 28
Pescara 28
Reggio Emilia 28
Norwalk 27
Shenyang 27
Taranto 27
University Park 27
Augusta 25
Hebei 25
Izmir 25
Livorno 25
Helsinki 23
Marseille 23
Bremen 22
Cagliari 22
Lucca 22
Kunming 21
Monza 20
Toronto 20
Trieste 20
Zhengzhou 20
Changsha 19
Munich 19
Salerno 19
Leawood 18
Modena 18
Rimini 18
Jiaxing 15
London 15
Caserta 14
Tianjin 14
Andover 13
Cambridge 13
Cesano Maderno 13
Frankfurt am Main 13
Santa Clara 13
Amsterdam 12
Novara 12
Piacenza 12
Pune 12
Shanghai 12
Hanoi 11
Hong Kong 11
Lecce 11
San Francisco 11
São Paulo 11
Totale 8.298
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 8.872
Accidental transplantation of a kidney with stones: case report 155
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 144
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 139
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 125
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 123
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 123
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 120
Effects of Switching from Twice-Daily to Once-Daily Tacrolimus Formulation on Quality of Life, Anxiety, and Transplant Benefit Perception after Kidney Transplantation 119
Belatacept utilization recommendations: an expert position 117
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 116
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results 116
Contrast-enhanced Voiding US for Grading of Reflux in Adult Patients Prior to Antireflux Ureteral Implantation1 116
HIGH-DOSE ATORVASTATIN REDUCE OXIDATIVE STRESS OF ISCHEMIA/REPERFUSION INJURY AFTER ISOGENEIC KIDNEY TRANSPLANTATION IN RATS 109
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 101
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 98
Interventional radiological treatment of renal transplant complications: a pictorial review 97
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 97
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 96
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study. 95
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 94
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 94
Complete clinical remission of psoriasis 6 months after renal transplantation 93
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results. 92
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 89
Preoperative Psychological Factors Predicting Graft Rejection in Patients Undergoing Kidney Transplant: A Pilot Study 88
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 88
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 87
Significant improvement in patient survival after renal transplantation in the last decade. 87
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 87
Andamento temporale di alcune proteine della fase acuta dopo trapianto di rene 86
[Nitrogen loss after kidney transplantation: effects of immunosuppressive therapy] 86
INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS 85
Extended-Release Tacrolimus Plus Everolimus or Micophenolate Mofetil in Deceased Donor Kidney Transplant Recipients: 6-Month Results of a Prospective Randomized Clinical Trial 85
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 85
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 84
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 82
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 82
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 79
RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES 77
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 77
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 75
PRELIMINARY RESULTS FROM A PROSPECTIVE MULTICENTER STUDY REVEAL THE EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION 75
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 75
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 74
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 74
Emotional management and quality of life in mother living versus multi-organ donor renal transplant recipients 74
Evolution of causes of mortality in renal transplantation in the last 10 years 73
Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? 73
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 72
Belatacept utilization recommendations: an expert position 71
Anonymity and live-donor transplantation: an ELPAT view 71
Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms 71
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 71
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 70
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 70
Perioperative-, recipient-, and donor-related factors affecting delayed graft function in kidney transplantation 70
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 68
ONE-SHOT VERSUS MULTIDOSE PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS AFTER KIDNEY TRANSPLANTATION: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL 67
Isoprinosine effects on postoperative immunodepression 66
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 66
[Organ transplantation: training and prospects for a young surgeon] 66
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 66
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 66
Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation: A Critical Review of the Literature 65
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 65
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 64
Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature 64
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 64
Immunosoppressive Therapy and Risk of Post-Transplant Malignancies after Kidney Transplantation: Italian Multicentric Study 63
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 63
Surgical Antibiotic Prophylaxis After Renal Transplantation: Time to Reconsider. 63
Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients 62
Re: Complete Clinical Remission of Psoriasis 6 Months After Renal Transplantation Response 62
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 61
Belatacept utilization recommendations: an expert position 60
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 60
COVID-19 and kidney transplantation: an Italian Survey and Consensus 60
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 59
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 59
Dealing With Public Solicitation of Organs From Living Donors--An ELPAT View 59
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 59
Radiofrequency thermal ablation of renal graft neoplasms: A literature review 59
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 58
Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 58
Global Kidney Exchange: opportunity or exploitation? An ELPAT/ESOT appraisal 57
Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature 56
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results 56
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 56
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 56
Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study 56
Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study 55
Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23 55
Anonymity and live-donor transplantation: an ELPAT view 55
Dealing With Public Solicitation of Organs From Living Donors-An ELPAT View 55
Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23 54
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009 54
Recommendations on Anonymity in Living Kidney Donation: An ELPAT View 54
Prediction, prevention, and management of delayed graft function: where are we now? 54
Outcome of liver transplatation after acute rejection and sepsis 53
Totale 16.622
Categoria #
all - tutte 55.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020447 0 0 0 0 0 0 0 19 49 41 193 145
2020/20211.146 71 125 29 125 157 100 125 31 152 33 176 22
2021/20221.336 84 125 27 52 46 55 37 227 49 98 267 269
2022/20233.797 332 348 192 452 177 432 152 343 495 203 385 286
2023/20244.961 284 576 300 374 340 488 402 417 349 444 487 500
2024/20254.498 492 664 689 565 691 508 517 372 0 0 0 0
Totale 18.568